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Original ArticleThe adaptor protein PID1 regulates receptor-
dependent endocytosis of postprandial
triglyceride-rich lipoproteinsAlexander W. Fischer 1,3, Kirstin Albers 1,3, Lucia M. Krott 1, Britta Hoffzimmer 1, Markus Heine 1,
Hartwig Schmale 1, Ludger Scheja 1, Philip L.S.M. Gordts 2, Joerg Heeren 1,*ABSTRACT
Objective: Insulin resistance is associated with impaired receptor dependent hepatic uptake of triglyceride-rich lipoproteins (TRL), promoting
hypertriglyceridemia and atherosclerosis. Next to low-density lipoprotein (LDL) receptor (LDLR) and syndecan-1, the LDLR-related protein 1
(LRP1) stimulated by insulin action contributes to the rapid clearance of TRL in the postprandial state. Here, we investigated the hypothesis that
the adaptor protein phosphotyrosine interacting domain-containing protein 1 (PID1) regulates LRP1 function, thereby controlling hepatic
endocytosis of postprandial lipoproteins.
Methods: Localization and interaction of PID1 and LRP1 in cultured hepatocytes was studied by confocal microscopy of fluorescent tagged
proteins, by indirect immunohistochemistry of endogenous proteins, by GST-based pull down and by immunoprecipitation experiments. The
in vivo relevance of PID1 was assessed using whole body as well as liver-specific Pid1-deficient mice on a wild type or Ldlr-deficient (Ldlr/)
background. Intravital microscopy was used to study LRP1 translocation in the liver. Lipoprotein metabolism was investigated by lipoprotein
profiling, gene and protein expression as well as organ-specific uptake of radiolabelled TRL.
Results: PID1 co-localized in perinuclear endosomes and was found associated with LRP1 under fasting conditions. We identified the distal NPxY
motif of the intracellular C-terminal domain (ICD) of LRP1 as the site critical for the interaction with PID1. Insulin-mediated NPxY-phosphorylation
caused the dissociation of PID1 from the ICD, causing LRP1 translocation to the plasma membrane. PID1 deletion resulted in higher LRP1
abundance at the cell surface, higher LDLR protein levels and, paradoxically, reduced total LRP1. The latter can be explained by higher receptor
shedding, which we observed in cultured Pid1-deficient hepatocytes. Consistently, PID1 deficiency alone led to increased LDLR-dependent
endocytosis of postprandial lipoproteins and lower plasma triglycerides. In contrast, hepatic PID1 deletion on an Ldlr/ background reduced
lipoprotein uptake into liver and caused plasma TRL accumulation.
Conclusions: By acting as an insulin-dependent retention adaptor, PID1 serves as a regulator of LRP1 function controlling the disposal of
postprandial lipoproteins. PID1 inhibition provides a novel approach to lower plasma levels of pro-atherogenic TRL remnants by stimulating
endocytic function of both LRP1 and LDLR in the liver.
 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Disturbances in lipid and lipoprotein metabolism promote the devel-
opment and progression of atherosclerosis [1,2]. Next to elevated low-
density lipoproteins (LDL), the accumulation of plasma triglyceride-rich
lipoproteins (TRL) and their remnants is an important risk factor for
cardiovascular disease [3]. TRL are secreted from the liver as very low-
density lipoproteins (VLDL) and from the intestine as chylomicrons.
Both are processed by lipoprotein lipase (LPL) at the vascular endo-
thelium, mediating the release of free fatty acids that are taken up by
adipose tissues and muscles. LPL remains associated after lipolysis1Department of Biochemistry and Molecular Cell Biology, University Medical Center Ham
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Both proteins interact with lipoprotein receptors that promote the
efficient endocytosis of TRL remnants into hepatocytes [4e6], a pro-
cess determining the plasma levels of these pro-atherogenic lipopro-
teins [7]. In addition to syndecan-1 and the LDLR, the LDLR-related
protein 1 (LRP1) is an important endocytic receptor that is especially
relevant for the uptake of postprandial chylomicron remnants [5,8,9].
One main characteristic of obesity and the Metabolic Syndrome is the
accumulation of TRL and their remnants in the circulation [10]. This is
explained in part by hepatic and intestinal insulin resistance, which is
associated with increased secretion of both VLDL and chylomicronsburg-Eppendorf, 20246, Hamburg, Germany 2Department of Medicine, University of
versity Medical Center Hamburg Eppendorf, Martinistrasse 52, 20246, Hamburg,
Available online 30 July 2018
mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
www.molecularmetabolism.com
[10e12]. In addition, impaired insulin-dependent TRL processing by
adipose tissue LPL contributes to postprandial hyperlipidemia [13].
Previously, we demonstrated the relevance of compromised hepatic
TRL remnant uptake in insulin resistant mice [14]. Mechanistically,
Descamps et al. showed that insulin stimulates LRP1 trafficking from
perinuclear vesicles to the plasma membrane in adipocytes [15]. A
similar mechanism for LRP1 translocation in the liver, facilitating the
hepatic clearance of atherogenic TRL remnants, was described by
Laatsch et al. [14]. Furthermore, we found that this process is
dependent on the distal NPxY motif in the LRP1-intracellular domain
(LRP1-ICD) [16]. However, the mechanisms regulating perinuclear
retention as well as insulin-mediated translocation of LRP1 have not
been identified. The protein phosphotyrosine interacting domain con-
taining 1 (PID1) was recently identified by pulldown experiments [17]
and Yeast two Hybrid [18] as an intracellular binding partner of LRP1.
PID1 is a close relative of the autosomal recessive hypercholester-
olemia (ARH) protein, an essential hepatic adaptor protein regulating
LDLR-mediated endocytosis [19]. ARH can also bind to the distal NPxY
motif of LRP1 but it does not regulate endocytic LRP1 function in the
liver [20]. By using in vitro and in vivo genetic models, we here show
that PID1 serves as an intracellular retention adaptor protein for LRP1
in hepatocytes. Phosphorylation of the distal NPxY motif disrupts PID1
binding to the LRP1-ICD, which leads to the insulin-dependent
translocation and accumulation of LRP1 at the hepatocyte cell sur-
face. Thus, by controlling LRP1 localization, PID1 determines hepatic
clearance and consequently plasma levels of pro-atherogenic TRL
remnants in the postprandial phase.
2. MATERIALS AND METHODS
2.1. Generation of knockout mice
The “Knockout-First-Reporter Tagged Insertion” Pid1tm1a(KOMP)Wtsi
allele present in the ESC clone EPD0579_4_G03 obtained from the
NCRR-NIH supported KOMP Repository (www.komp.org) was
generated through insertion of the L1L2_Bact_P cassette into intron 2
of the Pid1 gene at position -84038956 of mouse chromosome 1
(Figure S1). Cells from the clone EPD0579_4_G03 were injected into
C57BL/6J blastocysts to generate chimeras. Male chimeric offspring
was crossed with C57BL/6J females and the resulting offspring was
analysed for transmission of the targeted allele. Pid1tm1a mice were
genotyped by PCR using Pid1-specific primers flanking the 30 loxP
site downstream of the critical exon 3 (forward 50-GACATT-
GAAACCTGCTGCTG-3’; reverse 50-TCTAGCGCGCTGTTAGTTGT-30)
amplifying PCR products of 405 and 462 bp from the wild-type and
targeted locus, respectively. Pid1tm1a mice were backcrossed to
C57BL6/J for at least 7 generations and homozygous mice displaying
total PID1 knockout (Pid1/) were generated by heterozygous
breeding. Wild type littermates were used as controls. To generate
tissue-specific PID1-deficient mice, Pid1tm1a mice were crossed with
flippase (Flp)-expressing mice to delete the FRT-flanked selection
cassette and generate mice with a floxed exon 3 in the Pid1 gene
(Figure S1). These mice were then crossed with mice expressing Cre-
recombinase under control of the albumin promotor (Alb-Cre) to
generate liver specific knockouts (Pid1fl/fl-AlbCreþ). These mice
were subsequently crossed with global LDLR knockout mice to
generate liver specific Pid1-knockouts (Ldlr/- Pid1fl/fl-AlbCreþ) and
respective Cre-negative littermates (Ldlr/- Pid1fl/fl-AlbCre-) as con-
trols. Animal care and experimental procedures were performed with
approval from the animal care committees of the University Medical
Center Hamburg-Eppendorf. We used 12e18 week old male mice
that were kept on a 12-h light/dark cycle and fed either chow diet or aMOLECULAR METABOLISM 16 (2018) 88e99  2018 The Authors. Published by Elsevier GmbH. This is an
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for 8 weeks starting at 8 weeks of age. Mutant LRP1-knockin mice
lacking a function distal NPxY motif were kindly provided by A.
Roebroeck [24].
2.2. Cell culture
Human hepatoma cells (HuH7) were transiently transfected with
LRP1eGFP and PID1-RFP using FuGene according to the instructions of
the company (Promega). Respective vectors were made in-house
using standard molecular biology technologies. HuH7 cells were
grown in DMEM supplemented with 10% FCS and penicillin/strepto-
mycin/puromycin at 37 C and 5% CO2. Primary murine hepatocytes
were prepared by liver perfusion, EDTA dissociation and centrifugation
on a self-generating Percoll gradient to separate hepatocytes from
non-parenchymal cells [14] and were seeded in DMEM containing
10% FCS to a density of 2  105 cells/ml in collagen-coated wells on
glass coverslips for immunofluorescence analysis. For PID1 knock-
down in primary hepatocytes, the MISSION esiRNA targeting mouse
Pid1 (SigmaeAldrich, EMU030571) was transfected 4 h after seeding
using lipofectamin2000 (Invitrogen by life technologies). Experiments
were carried out two days after transfection of esiRNA.
2.3. Antibodies
Antibodies used in the study were: sheep polyclonal anti-LRP1 “dolly”
(made in-house, WB 1:500), mouse monoclonal anti-LRP1 (11H4, WB
1:1200), rabbit polyclonal anti-Flag (SigmaeAldrich, F7425, WB
1:300), mouse monoclonal ezview red anti-Flag M2 affinity gel
(SigmaeAldrich, F2426, 40 ml for IP), mouse monoclonal phospho-
tyrosine (clone 4G10, Upstate, 05-321, WB 1:1000). Mouse mono-
clonal anti-b-actin (SigmaeAldrich, A5441, WB 1:20000), rabbit
polyclonal anti-early endosome antigen 1 (EEA1, Abcam, ab50313, IF
1:250); rabbit polyclonal anti-PID1 (SigmaeAldrich, HPA36103; WB/IF
1:200), rabbit monoclonal anti-LRP1 (Abcam, ab92544, WB 1:10000;
IF: 1:500), anti-SR-B1 (kindly provided by F. Rinninger, Hamburg,
Germany; WB 1:1000), anti-apolipoprotein E (APOE, Acris, TA326636;
1:1000), goat polyclonal anti-LDLR (R&D Systems, AF2255, WB
1:1000) and rabbit-polyclonal anti-Calnexin (Abcam, ab22595; WB
1:1000). An affinity purified rabbit anti-PID1 antibody was raised
against the synthetic peptide LCTTTPLMKARTHSG corresponding to 15
amino acids located in exon 2 of PID1 and used to detect Flag-PID1 in
the pull down experiments. All of the following secondary antibodies
were purchased from Jackson Immuno Research: donkey anti-mouse
Alexa Fluor 555 (IF 1:1000), donkey anti-mouse Alexa Fluor 647 (IF
1:1000), donkey anti-mouse Cy3 (IF 1:500), goat anti-rabbit HRP (WB
1:5000), goat anti-mouse Alexa Fluor 488 (IF 1:1000), goat anti-mouse
HRP (WB 1:5000), donkey anti-sheep HRP (WB 1:10000) and donkey
anti-rabbit Cy2 (IF 1:1000).
2.4. Immunofluorescence
For immunofluorescence experiments, cells were washed with PBS,
fixed with 4%PFA and indirect immunofluorescence against LRP1,
PID1, and EEA1 was performed using standard procedures. Localization
of proteins within the cells was visualized by confocal laser scanning
microscopy using a Zeiss LSM710 or a Nikon A1R. To analyse the
localization of LRP1 in hepatocytes before and after insulin stimulation,
primary wild type and Pid1/ hepatocytes were generated as
described above and seeded to a density of 1 105 cells/ml onto glass
coverslips. Hepatocytes were washed once with PBS and incubated
with 10 nM Insulin in DMEM supplemented with 10% FCS for 10 min at
37 C. Then, cells were washed with PBS, fixed with 4% PFA and
analysed by using indirect immunofluorescence as described above.open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 89
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Western blots were performed using standard procedures. Cells were
lysed in lysis buffer (2 mM CaCl2, 80 mM NaCl, 1% TritonX-100,
50 mM Tris/HCl, pH 8.0) supplemented with Complete Mini protease
inhibitor cocktail (Roche). Snap-frozen tissue samples were lysed in
RIPA buffer (50 mM Tris-HCl pH7.4, 5 mM EDTA, 150 mM NaCl, 1 mM
Na-Pyrophosphate, 1 mM NaF, 1 mM Na-Vanadate, 1% NP-40) sup-
plemented with Complete Mini protease inhibitor cocktail (Roche) and
0.1% SDS using the TissueLyser (Qiagen). Protein concentrations were
determined using the Lowry method and subsequently, proteins were
separated on NuPAGE Bis-Tris 4e12% gradient gels (Invitrogen) or
10% Tris-glycine gels. For western blotting, proteins were transferred
to nitrocellulose membranes, blocked for 1h in 5% milk in TBS-T
(20 mM Tris, 150 mM NaCl, 0.1% (v/v) Tween 20) and incubated
overnight at 4 C in the respective primary antibodies, diluted in 5%
BSA in TBS-T. After washing in TBS-T, the membranes were incubated
with respective secondary horseradish peroxidase-labelled antibodies.
Signals were detected with enhanced chemiluminescence (ECL) using
Amersham Hyperfilm (GE Healthcare) or Amersham Imager 600 (GE),
and quantification was carried out using ImageJ.
2.6. GST-pulldown experiments
For purification of GST-fusion proteins, the GST expression vector
(pGex-6P, GE Healthcare) as well as the Flag-expression vector pCMV-
Tag2B, both containing the respective insert (murine PID1; wild type and
mutated LRP1 ICD; see Figure S2 for structure and mutations of the
intracellular LRP1 domain) were transformed into E. coli BL21 (Stra-
tagene). GST fusion proteins were purified via Glutathion Sepharose 4B
(GE Healthcare). LRP1-ICDs were released from the column by incu-
bation with PreScission protease (GE Healthcare). Integrity of all re-
combinant proteins was confirmed by SDS-PAGE. For pulldown analysis
either cell or tissue lysates (150 mg) were incubated over night at 4 C
with GST-fusion proteins. Subsequently pulldown and unbound frac-
tions were separated by centrifugation for 3 min at 9000 rpm. Super-
natants were harvested (unbound fraction) and sepharose pellets were
washed six times using PBS. Finally, pellets were reduced, and PID1-
interacting proteins were analysed by Western blotting.
2.7. Immunoprecipitation
To analyse LRP1-PID1 interaction, constructs coding for the Flag-PID1
fusion protein and the LRP1-cytoplasmic tail were co-expressed in
human embryonic kidney cells (HEK 293T). Cell lysates were incubated
with anti-Flag M2 affinity gel or Protein G bound LRP1 specific antibody
for 12 h at 4 C on a rotator, respectively. Elution was performed using
NuPage SDS sample buffer containing reducing agent (1x, Invitrogen
by life technologies) for 5 min at 95 C. Proteins were detected by
Western blotting.
2.8. mRNA expression analysis
Total RNA was isolated from cells and organs using TRIzol (Invitrogen
by life technologies) and a NucleoSpin RNAII kit (Macherey und Nagel)
according to manufacturer’s instructions. After DNase treatment
(RNase-free DNase set, Qiagen), 1 mg of RNA was used for cDNA
preparation (High-Capacity cDNA Reverse Transcription Kit, Applied
Biosystems) according to manufacturer’s instructions. Quantitative
real-time RT-PCR was performed using assays-on-demand primer/
probe sets provided by Applied Biosystems (Assay IDs: mPid1,
Mm01545237_m1; mLrp1, Mm00464608_m1; mTbp,
Mm00446973_m1). Relative mRNA expression was calculated by the
DDCT method and normalized to housekeeper mRNA (Tbp) as
described [21].90 MOLECULAR METABOLISM 16 (2018) 88e99  2018 The Authors. Published by Elsevier G2.9. Biotinylation
In vivo biotinylation was performed as described in detail elsewhere
[22]. Briefly, wildtype and Pid1/ mice were i.p. injected with ace-
promazin (Sigma, 3 mg/kg body weight) to promote vasodilatation and
anaesthetized using ketamine/rompun. Then, mice were perfused first
with 10 ml of pre-warmed PBS supplemented with 10% dextrane 40
for 10 min, subsequently with biotinylation buffer containing non-
permeable, cleavable 1 mg/ml EZ Link Sulfo-NHS-SS-Biotin (Thermo
Scientific) in PBS containing 10% dextrane 40 for 10 min at 37 C, and
finally with 50 mM Tris/HCl in PBS containing 10% dextrane 40 for
10 min at 37 C to inactivate EZ Link Sulfo-NHS-SS-Biotin. Livers were
lysed in cell lysis buffer and equal protein amounts of each sample
were incubated with pre-washed PierceTM Streptavidin Magnetic
Beads (Thermo Scientific) according to manufacturer’s instructions at
4 C for 90 min on a rotator. Afterwards, magnetic beads were washed
twice with TBS containing Tween20 and twice with PBS. Biotinylated
proteins were subsequently eluted with NuPage SDS sample buffer
containing reducing buffer (1x, Invitrogen by life technologies) and
analysed by SDS-PAGE and western blotting.
2.10. Plasma analysis
Mice were fasted for 4 h. Blood was collected via the tail vein or
by cardiac puncture of anaesthetized mice. Plasma cholesterol and
triglyceride were determined using commercial kits (Roche) ac-
cording to manufacturer’s instructions. For analysis of lipoprotein
classes, fast protein liquid chromatography (FPLC) was performed.
Plasma samples from several mice were pooled and size exclusion
chromatography was performed on a S6-FPLC column. Choles-
terol- and triglyceride content was determined in the different
fractions.
2.11. Lipid uptake studies
Oral fat tolerance tests traced with 12 KBq [9,10-3H(N)]-triolein/g
body weight were performed as described [23]. Briefly, mice were
fasted for 4 h before receiving an oral gavage of olive oil containing
[9,10-3H(N)]-triolein. Four hours after gavage, mice were anaes-
thetized with ketamine/rompun. Then, mice were transcardially
perfused with PBS containing 10U/ml heparin to release LPL-bound
TRLs. Organs were solubilized in 10x (v/w) solvable (Perkin Elmer)
at 60 C and radioactivities were determined using Aquasafe 300
Plus scintillation liquid (Zinsser Analytic) in a liquid scintillation
counter (Perkin Elmer Tricarb).
2.12. Intravital microscopy
Intravital microscopy was performed as described previously [24].
Briefly, fasted mice were i.p. injected with saline or insulin-saline
(1U/kg body weight). After 10 min, mice were anaesthetized using
isoflurane inhalation anaesthesia. The tail vein was catheterized,
skin and peritoneum were opened, and the liver was prepared and
attached to a cover glass. Microscopy was performed using a Nikon
A1 confocal microscope equipped with a Resonant Scanner for
image acquisition at 30 fps. For visualization of LRP1 translocation,
100 mg of Cy5-labelled anti-LRP1 antibody in 100 ml saline were
injected via tail vein catheter and the binding of the antibody was
monitored for 10 min. Antibody labelling was performed using a
commercial kit (Cy5-labelling kit GE Healthcare). 1 mg of antibody
was incubated with the dye mix in a 0.1 M Bicarbonate-Solution for
1 h at room temperature and 300 rpm shaking. Afterwards, free dye
was removed using a PD10 size exclusion column (GE healthcare).
During this procedure, the buffer was replaced by 0.9% NaCl
solution.mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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2.13. Determination of hepatic lipid content
To measure the hepatic lipid content, tissue samples were homoge-
nized in RIPA buffer (see above) and protein concentration was
determined using the Lowry method. Triglyceride content in the liver
extract was measured with commercial triglyceride kit (Roche) ac-
cording to manufacturer’s instructions. For quantification of cholesterol
content, 50 ml of liver homogenate were mixed with 1 ml chloroform/
methanol (8:5 v/v) and centrifuged at 13000 rpm for 5 min. The su-
pernatant was dried and reconstituted in 200 ml AmplexRed reaction
buffer (Invitrogen) for 20 min at 50 C on a shaker. Cholesterol con-
centration was measured using AmplexRed Cholesterol Assay Kit
(Invitrogen) according to the manufacturer’s instructions.
2.14. Statistical analyses and data processing
Two-tailed, unpaired Student’s t-test was performed to calculate
statistical significance. P < 0.05 was considered to be statistically
significant.
3. RESULTS
3.1. Interaction of PID1 and LRP1
We determined the expression PID1 and LRP1 in a mouse organ panel
to identify tissues with high abundance of both these proteins as po-
tential sites of interaction (Figure 1A). LRP1 is widely expressed with the
highest levels in the liver, followed by brown adipose tissue, lung, and
brain. Notably, the pattern of PID1 is very similar with the highest
expression also in the liver (Figure 1A). This co-expression is consistent
with a potential role of PID1 as an adaptor protein controlling LRP1
function in liver and other organs. To investigate the interaction of the
two proteins at the cellular level, human hepatoma HuH7 cells were
transfected with PID1-RFP and LRP1-eGFP. Confocal microscopy indi-
cated that these fluorescent-tagged versions of LRP1 and PID1 co-
localized in EEA1-positive early endosomes primarily located within
the perinuclear region (Figure 1B). A similar distribution was found for
endogenous LRP1 and PID1 in primary murine hepatocytes (Figure 1C),
providing evidence for an interaction of the two proteins. To determine
the molecular basis of this interaction, immunoprecipitation (IP) and
GST-based pulldown experiments were conducted. Co-transfection
studies in HEK293T cells showed binding of FLAG-tagged PID1 to the
LRP1 carboxyl-terminus (LRP1-CT), which contains the cytoplasmic as
well as the transmembrane domain of the LRP1-b-chain (Figure 2A and
Fig. S2). The LRP1-ICD contains three putative phosphorylation motifs,
a serine phosphorylation motif (RxS76), and two tyrosine phosphoryla-
tion sites within the proximal and distal NPxY-motifs. The latter one
overlaps with a YxxL motif, forming a 60NPxYxxL66 double motif
(Fig. S2). The potential role of these motifs for the interaction of PID1
and LRP1 was further characterized using pulldown experiments with a
GST-PID1-fusion protein in combination with recombinant wild type
(WT) and mutant LRP1-ICDs (Figure 2B). GST-PID1 was able to bind
wild type LRP1-ICD as well as the LRP1-ICD lacking a functional
proximal NPxY domain. However, the GST-PID1 did not interact with
LRP1-ICDs lacking a functional distal NPxY domain (Figure 2B), indi-
cating that PID1 binds to the distal NPxY motif. Single amino acid
substitution identified the asparagine at position 60 and the tyrosine at
position 63 within the distal NPxY motif as being critical for the LRP1-
PID1 interaction (Figure 2C). In vivo experiments confirmed these
findings, as purified GST-PID1 fusion protein was able to pull down
LRP1 (Figure 2D, upper panel) but not the LDLR (Figure 2E) from wild
type liver lysates. In line with the in vitro data and as shown in the lower
panel of Figure 2D, GST-PID1 was unable to pull down LRP1 from liver
lysates of knockin mice expressing a mutated distal NPxY motif [25].MOLECULAR METABOLISM 16 (2018) 88e99  2018 The Authors. Published by Elsevier GmbH. This is an
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binding affinity of adaptor proteins [26]. Thus, we investigated
whether phosphorylation of the tyrosine residue in the distal NPxY of
LRP1 affects PID1 binding in pulldown experiments with LRP1-ICD
constructs mutated at tyrosine 63. The residue was mutated to
glutamate (Y63E) and to phenylalanine (Y63F) to mimic a constitutively
phosphorylated and non-phosphorylated distal NPxY, respectively.
The Y63F but not the Y63E protein was pulled down (Figure 2C),
indicating that PID1 binds only to the non-phosphorylated LRP1-ICD.
The observed sensitivity of PID1 binding to phosphorylation of the
LRP1 NPxY motif was confirmed using constructs that were partially
in vitro phosphorylated by v-Src-kinase [27]. In the pull down fraction,
we detected only non-phosphorylated LRP1-ICD, as indicated by
absence of phospho-tyrosine (pY) immunoreactivity (Figure 2F). In
contrast, both phosphorylated wild type and mutated proteins lacking
only the functional proximal NPxY were detected in the supernatant
only after treatment with v-Src kinase, coinciding with their phos-
phorylation (Figure 2F). Constructs lacking the distal NPxY motif did
not get phosphorylated by v-Src-kinase treatment, and as shown
before did not bind PID1 as the respective LRP1-ICDs were found in
the supernatants. Altogether, these results demonstrate that PID1 co-
localizes with LRP1 in perinuclear endosomes of hepatocytes and
binds specifically to the non-phosphorylated distal NPxY motif of
LRP1.
3.2. PID1 controls LRP1 localization and abundance in hepatocytes
in vitro and in vivo
To investigate the role of PID1 for LRP1 function, we performed
siRNA-mediated silencing of PID1 in primary murine hepatocytes
(Figure 3A). Typical LRP1 perinuclear staining was observed in
control cells, whereas PID1 knockdown resulted in a predominant
plasma membrane localization of LRP1 (Figure 3B). These results
indicate that PID1 is crucial for LRP1 localization. Moreover, its
depletion cannot be compensated by other hepatic adaptor proteins,
which prompted us to study the in vivo relevance of PID1 in total body
knockout (Pid1/) mice. The Pid1/ mice were viable and showed
an effective reduction of Pid1 mRNA in various organs (Figure S3A)
with minor effects on LRP1 expression (Figure S3B). Hepatocyte LRP1
has been shown to translocate from perinuclear regions to the
plasma membrane in response to insulin treatment [14]. This insulin-
dependent LRP1 localization was confirmed in primary hepatocytes
isolated from wild type mice (Figure 3C). Similar to the results ob-
tained with siRNA-mediated PID1 knockdown (Figure 3B), we
observed high abundance of LRP1 at the cell surface already under
basal conditions in primary hepatocytes isolated from Pid1/ mice
(Figure 3C). Notably, this distribution was not further altered by in-
sulin administration (Figure 3C). The altered LRP1 localization was
confirmed by in vivo cell surface biotinylation experiments
(Figure 3D,E), as an enrichment of plasma membrane LRP1 over
whole tissue was observed in the absence of PID1. However, total
and cell surface LRP1 levels were lower in livers of Pid1/
compared to wild type mice. In line with the in vivo data, total LRP1
protein was also decreased in Pid1/ primary hepatocytes
(Figure 3F). In conjunction, we observed markedly increased LRP1
content in cell culture supernatants of Pid1/ primary hepatocytes
(Figure 3F), indicating that the reduction is explained by accelerated
shedding of the receptor. Additionally, altered intracellular sorting of
LRP1 leading to lysosomal degradation may contribute to the reduced
total LRP1 levels. In line with this, we observed partial co-localization
with the lysosomal marker LAMP1 in PID1-knockdown hepatoma
cells (Figure S3C). We also found a profound increase in hepatic LDLRopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 91
Figure 1: Expression and intracellular localization of PID1. (A) Protein expression of LRP1 and PID1 by western blot analysis in different organs of a C57BL6/J mouse. Calnexin was
used as loading control. Li - liver; iB - interscapular brown adipose tissue; iW - inguinal white adipose tissue; eW - epididymal white adipose tissue; H e heart; M quadriceps
muscle; Lu e lung; K e kidney; Sp e spleen; St e stomach; Pa e pancreas; Du e duodenum; Je e jejunum; Il e ileum; Col e colon; Br e whole brain; Hy e hypothalamus; Te
e testis; Sk e skin. (B) Human HuH7 hepatoma cells were transfected with expression vectors coding for PID1-RFP (red) and LRP1-eGFP (green). EEA1 (purple) was detected by
indirect immunofluorescence and confocal images were taken. A magnification of the merged image is shown on the right picture (bars: 10 mm). Nuclei were stained using DAPI
(blue). (C) Indirect immunofluorescence was performed to visualize endogenously expressed LRP1 (red) and PID1 (green) in murine wild type primary hepatocytes. Arrows indicate
co-localization. Nuclei were stained using DAPI (blue). Bars: 5 mm.
Original Articleexpression in Pid1/ mice (Figure 3G). The latter observation is in
line with the previously reported up-regulation of the LDLR in liver-
specific LRP1 knockout mice [8]. Consistently, plasma triglycerides
were significantly decreased in Pid1/ mice compared to wild type
controls (Figure 3H). This reduction in plasma triglycerides is92 MOLECULAR METABOLISM 16 (2018) 88e99  2018 The Authors. Published by Elsevier Gexplained by increased TRL uptake into livers of Pid1/ mice as
shown by an in vivo metabolic clearance study using radioactive 3H-
triolein (Figure 3I). Thus, PID1 inactivation leads to a reduction of
hepatic LRP1 protein that results in a compensatory LDLR up-
regulation and an associated accelerated lipoprotein clearance.mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 2: Interaction of PID1with the distal NPxY-motif of LRP1. (A) Co-immunoprecipitation (IP) with lysates of non-transfected control cells and HEK293T cells co-transfected with
Flag-PID1 and the C-terminal domain of LRP1 (LRP1-CT). IP was performed using an anti-Flag or an anti-LRP1 antibody. After western blotting, PID1 or LRP1 were detected using
specific antibodies in the IP fractions (I: input; SN: supernatant). (B) GST-PID1 pulldown experiments with wild type (WT) and mutant LRP1-ICD lacking the functional proximal (N1),
distal (N2) or both (N1/2) NPxY domains of LRP1-ICD. (C) GST-PID1 pulldown experiments with WT and LRP1-ICD mutated in single amino acids within the distal NPxY motif. (D)
GST-PID1 pulldown studies with liver lysates isolated from WT and LRP1 knockin mice lacking a functional distal NPxY domain. (E) GST-PID1 pulldown studies with liver lysates
isolated from WT and liver-specific Lrp1/ mice. (F) GST-PID1 pulldown with non-phosphorylated LRP1-ICD (ICD) and v-Src kinase phosphorylated LRP1 (pY-ICD).3.3. PID1 is an LRP1 perinuclear endosome retention adaptor
protein
We generated liver-specific PID1-knockout mice on a LDLR-deficient
background to separate direct effects of hepatic PID1 depletion on
LRP1 localization and abundance independent from its indirect effects
on hepatic LDLR expression (see Figure 3G). For this purpose, floxed
Pid1 (Pid1fl/fl) mice (Figure S1) were crossed with mice expressing Cre-
recombinase exclusively in the liver via the albumin promotor
(AlbCreþ), and subsequently crossed with Ldlr/- mice. Compared to
controls (Ldlr Pid1AlbCre-), recombination led to an effective reduction
of Pid1 mRNA expression in livers of Ldlr/ Pid1fl/flAlbCreþ, whereasMOLECULAR METABOLISM 16 (2018) 88e99  2018 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.comLrp1 mRNA levels were unaltered (Figure 4A). Western blot analysis
confirmed effective PID1 knockout, which, similar to the total PID1
knockout mice, was associated with a decrease in total hepatic LRP1
protein abundance (Figure 4B). To study the impact of PID1 on LRP1
redistribution from perinuclear compartments to the plasma mem-
brane in vivo, we performed intravital microscopy in Ldlr Pid1AlbCre-
and Ldlr Pid1fl/flAlbCre þ mice. Next we injected mice with insulin or
saline followed by a fluorescently labelled antibody against the
extracellular domain of LRP1 to visualize LRP1 abundance at the
plasma membrane as well as insulin-dependent translocation. In Ldlr
Pid1AlbCre-controls, we observed a low basal abundance of LRP1 atopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 93
Figure 3: Effects of PID1 deficiency on LRP1 expression, localization and function. (A) Expression of Pid1 mRNA and (B) localization of endogenous LRP1 (green) in primary murine
hepatocytes after transfection with scrambled or Pid1-specific siRNA. Nuclei are stained using DAPI (blue). Bar: 20 mm. (C) Primary hepatocytes isolated from WT and Pid1/ mice
were treated with or without 10 nM insulin for 15 min prior to indirect immunofluorescence against LRP1 (green). Nuclei are stained with DAPI (blue). Bar: 20 mm. (D) In vivo cell
surface biotinylation was performed in WT and Pid1/ mice. LRP1 expression was quantified in total liver lysates (Input) and the isolated plasma membrane (PM) fraction. b-actin
was used as loading control. (E) Densitometric analysis of the western blots comparing the ratio of plasma membrane to total LRP1 protein (n ¼ 4). (F) LRP1 detection in cell
lysates and supernatants (SN) of primary hepatocytes isolated from WT and Pid1/ mice. (G) Western blot analysis of PID1, LRP1, LDLR and b-actin in liver lysates of WT and
Pid1/ mice. (H) Plasma cholesterol and triglycerides in WT and Pid1/ mice (n ¼ 7e8). (I) Organ-specific uptake of 3H-labelled triolein after oral fat gavage in WT and Pid1/
mice (n ¼ 7e8). Data are presented as mean values  s.e.m. *P < 0.05.
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Figure 4: Expression and insulin-dependent localization of LRP1 in liver-specific Pid1/ mice knockout mice lacking the LDLR. To generate LDLR deficient mice with (Ldlr/
Pid1fl/fl AlbCre-) or without (Ldlr/ Pid1fl/fl AlbCreþ) hepatic PID1, LDLR deficient mice were crossed with Pid1-floxed mice and mice expressing Cre recombinase driven by the
liver-specific albumin promotor. (A) mRNA and (B) protein expression of PID1 and LRP1 in livers. (C) Densitometric analysis of the Western blots shown in B (n ¼ 4). (D) Intravital
microscopy of livers after treatment with either saline (- insulin) or 1 U/kg insulin (þinsulin). Cell surface LRP1 was visualized by injection of a Cy5-labelled antibody against LRP1
(green). Intravital microscopy was performed over a period of 10 min (see Supplemental Video): Images shown here were taken 10 min after antibody injection. Bars 25 mm.the cell surface of hepatocytes (Figure 4D upper left, Supplemental
Video). Insulin administration strongly increased cell surface fluores-
cence (Figure 4D lower left, Supplemental Video), indicating LRP1
translocation to the plasma membrane. In Ldlr Pid1AlbCreþ, basal
LRP1 staining was higher compared to the controls (Figure 4D upper
right, Supplemental Video). Similar to the results obtained in PID1-
deficient primary hepatocytes (Figure 3C), insulin treatment did not
further increase LRP1 plasma membrane levels in the absence of PID1
(Figure 4D lower right, Supplemental Video).
Supplementary video related to this article can be found at https://doi.
org/10.1016/j.molmet.2018.07.010.
Altogether, these data indicate that PID1 is a retention adaptor protein
that keeps LRP1 in perinuclear endosomes, preventing its shedding atMOLECULAR METABOLISM 16 (2018) 88e99  2018 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.comthe plasma membrane of hepatocytes in the basal state. Moreover,
unlike in wild type hepatocytes insulin was unable to stimulate
translocation of LRP1 to the plasma membrane in PID1-deficient he-
patocytes, suggesting that PID1 controls the endocytic capacity of
LRP1 in the postprandial state.
3.4. Hepatic PID1 regulates plasma lipoprotein levels
To determine the impact of hepatic PID1 on plasma lipoprotein
metabolism on the Ldlr/ background, Ldlr Pid1AlbCre- and Ldlr
Pid1AlbCre þ mice were fed either a chow or a cholesterol-rich
Western-type diet (WTD). Plasma analysis of fasted chow fed mice
revealed no significant alterations in plasma triglycerides and a modest
1.3-fold increase in total plasma cholesterol levels (Figure 5A). Thisopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 95
Original Articleincrement in circulating cholesterol levels coincided with a slight in-
crease in cholesterol-rich IDL and LDL particles (Figure 5B). Fasted
WTD-fed mice presented with a 2e3fold increase in plasma lipid levels
compared to the chow-fed group. Under WTD-fed condition the plasma
triglycerides levels in the PID1-deficient group were 1.9-fold higher
compared to the Ldlr Pid1AlbCre-controls, which was reflected by
higher triglyceride content in the TRL fraction (Figure 5A,C). Moreover,
WTD-fed Ldlr Pid1AlbCre þ mice had a significant reduction in liver
lipid content (Figure 5D). The data are consistent with impaired
clearance of postprandial remnant lipoproteins in Ldlr
Pid1AlbCre þ mice. To address this concept we performed an oral fat
tolerance study in chow fed mice using olive oil combined with
radioactive 3H-triolein. Under this postprandial condition, we observed
an accumulation of TRL and remnant lipoproteins (Figure 5E), whichFigure 5: Plasma lipid levels and uptake of postprandial lipoproteins in liver-specific Pid1
AlbCre-) or without (Ldlr/ Pid1fl/fl AlbCreþ) hepatic PID1 were investigated. (A) Total plasm
profiling of pooled plasma using fast protein liquid chromatography (FPLC) analysis of mi
normalized to protein content in fasted chow-fed mice (n ¼ 4). (E) Lipoprotein profile and
presented as mean values  s.e.m. *P < 0.05.
96 MOLECULAR METABOLISM 16 (2018) 88e99  2018 The Authors. Published by Elsevier Gwas accompanied by a reduction of hepatic triolein uptake in Ldlr
Pid1AlbCreþ mice compared to controls (Figure 5F). Altogether, these
data indicate that hepatic PID1 is critically involved in the regulation of
LRP1 endocytic function, and thereby modulates plasma lipoproteins
levels especially in the postprandial state.
4. DISCUSSION
PID1 was originally identified in a suppression subtractive hybridization
study as a novel gene being expressed to a higher level in subcu-
taneous adipose tissue from obese subjects [28], which suggests that
PID1 could play a role in the development of obesity associated
metabolic abnormalities such as hyperlipidemia and hyperglycemia.
Sequence homology between murine and human PID1 is very high/ mice knockout mice lacking the LDLR. LDLR deficient mice with (Ldlr/ Pid1fl/fl
a lipid levels in mice fed a chow (n ¼ 9) or Western type diet (n ¼ 6). (B,C) Lipoprotein
ce fed a (B) chow or (C) Western type diet. (D) Liver cholesterol and triglyceride levels
(F) organ-specific uptake of 3H-labelled triolein after oral fat gavage (n ¼ 6). Data are
mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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(96%, Fig. S4), implying a critical role of this adaptor protein for cellular
trafficking. In line, PID1 levels were found to be inversely correlated
with glucose uptake in adipocytes and myotubes [29,30]. Mechanistic
insights into how PID1 functions in vivo are lacking, and the role of
PID1 in the liver has not been studied at all. Using proteomicFigure 6: The retention adaptor PID1 as a regulator of LRP1 localization and function. (A) In
motif of the intracellular domain of LRP1. This causes the retention of LRP1 in perinuclea
causes the phosphorylation of the distal NPxY motif of LRP1, resulting in the dissociatio
membrane leading to exposure of LRP1 to mediate effective endocytosis of postprandia
compartments, and thus distributed to the plasma membrane. The constitutive presence
levels. Despite impaired LRP1 function, the compensatory up-regulation of the LDLR cause
LRP1 by shedding leads to impaired endocytosis and accumulation of plasma lipoprotein
MOLECULAR METABOLISM 16 (2018) 88e99  2018 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.comapproaches, two studies showed that the cytosolic protein PID1 is an
intracellular binding partner for LRP1 [17,18], a lipoprotein receptor
showing a perinuclear distribution in the basal state [14,31,32]. In this
study, we provide evidence that PID1 via its binding to the non-
phosphorylated, distal NPxY motif in the LRP1-ICD, sequesters thehepatocytes of fasted wild type mice, the adaptor protein PID1 binds to the distal NPxY
r compartments. (B) In the postprandial phase, anabolic signalling mediated by insulin
n of PID1. Subsequently, LRP1-containing endosomes vesicles fuse with the plasma
l lipoproteins. (C) In PID1-deficient hepatocytes, LRP1 is not retained in perinuclear
at the cell surface leads to increased shedding and consequently lower LRP1 protein
s lower plasma lipoprotein levels. (D) Accordingly, when the LDLR is absent the loss of
s.
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 97
Original Articlereceptor in endosomal compartments, thereby controlling LRP1
function. PID1 contains a phospho-tyrosine binding domain but lacks
additional motifs that could mediate the association to the endosomal
sorting machinery. In contrast, ARH, a close relative of PID1, binds the
NPXY motif of the LDLR and thereby attaches this receptor to the
endocytic machinery to mediate clathrin-dependent endocytosis [33].
Here we show that the dissociation of PID1 from the distal NPXY motif
results in higher abundance of LRP1 at the plasma membrane.
Together with the observation that the distal PID1-binding NPXY motif
of LRP1 does not serve as an endocytosis signal [34], our data indicate
that PID1 does not connect LRP1 to clathrin and/or AP-2 for endocy-
tosis. Rather, we propose that PID1 belongs to a wider class of
retention adaptor proteins that retain signalling and endocytic re-
ceptors in a perinuclear compartment during quiescent phases. The
phosphorylation of such NPxY-containing receptors can be triggered by
a signalling event leading to the dissociation of these retention
adaptors. It has been demonstrated that LRP1 is phosphorylated in
response to insulin [35,36], and we previously found that insulin
mediates the translocation of LRP1 from hepatic perinuclear recycling
endosomes to the plasma membrane in the postprandial state [14]. In
the present study, we show that phosphorylation of the tyrosine res-
idue within the distal NPxY motif resulted in dissociation of PID1 from
the LRP1-ICD. Thus, PID1 functions as an insulin-dependent molecular
switch that regulates cellular LRP1 distribution and function. As
summarized in the model shown in Figure 6, PID1 binds to non-
phosphorylated LRP1-ICD prevalent in the fasted state. Upon post-
prandial insulin stimulation intracellular tyrosine kinases phosphorylate
the distal NPxY motif of LRP1. This event lowers the binding affinity of
PID1, enabling interaction with other adaptor proteins that sort LRP1 to
the plasma membrane. One of these proteins could be sorting nexin 17
(SNX17), an adaptor that binds to the proximal NPxY motif known to
mediate transport of LRP1 from endosomal compartments to the cell
surface [37]. Notably, this process requires proper phosphorylation of
Y63 within the distal NPxY motif [38,39]. This observation aligns with
our model where PID1 is the molecular switch determining LRP1
localization and translocation possibly by preventing SNX17 binding in
the basal state but allowing SNX17 binding after insulin-stimulated
LRP1 phosphorylation (Figure 6). Potential interaction partners link-
ing PID1 to the perinuclear recycling compartment are e.g. vesicular
sorting proteins forming the retromer, a complex that regulates
endosome-to-plasma membrane trafficking of various receptors [40].
Alternatively, SNX17 recently has been linked to the endosomal cargo
sorting pathway as a retromer-independent sorting pathway involving
retriever, a recently discovered complex that couples to the CCC and
WASH complexes to prevent lysosomal degradation and promote cell
surface recycling [41]. Interestingly, the CCC complex is required for
the hepatic surface expression of LRP1 [42,43], supporting the hy-
pothesis that this retromer-independent pathway could mediate
insulin-dependent regulation of LRP1 trafficking via PID1. It remains to
be determined which proteins specifically interact with PID1 to confer
the perinuclear LRP1 retention.
Another important aspect of the present study is that knockout or
knockdown of PID1 in hepatocytes in vitro and in vivo results in the
constitutive presence of LRP1 at the plasma membrane. This cellular
redistribution was, however, accompanied by a reduction of hepato-
cyte LRP1 levels, probably due to receptor shedding which has been
described for this receptor [44]. Consistently, we observed that hepatic
clearance of TRL and TRL remnants was diminished and plasma lipids
were elevated in liver-specific Pid1/ mice in the absence of LDLR
expression. In stark contrast, Pid1 single knockout mice exhibited
accelerated TRL uptake in the liver, which is explained by higher98 MOLECULAR METABOLISM 16 (2018) 88e99  2018 The Authors. Published by Elsevier Ghepatic LDLR expression. A similar compensatory up-regulation of the
LDLR has previously been observed by us in mice carrying a knockin
mutation, which prevents the tyrosine phosphorylation of the distal
LRP1 NPxY motif [16].
In conclusion, this study shows for the first time the relevance of PID1
for hepatic LRP1 function and lipoprotein metabolism. Our results
indicate that reduction of PID1 expression in the liver, for example
through siRNA, provides a novel therapeutic approach to increase
LDLR activity to reduce the levels of circulating pro-atherogenic lipo-
proteins. From a cell biology perspective, it will be intriguing to follow
the concept of retention adaptor proteins and to elucidate the detailed
mechanism by which PID1 is able to retain LRP1 in a perinuclear
recycling compartment.
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